Please note: The information displayed on this page might be outdated.
Tango Therapeutics: Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of targeted therapies to people with cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at driver genes in cancer for patients with limited treatment options. The company is focused on three core areas: counteracting tumor suppressor gene loss, reversing the ability of cancer cells to evade the immune system and identifying novel combinations that will be more effective than single agent therapy. Tango was launched in 2017 with a $55 million Series A investment funded by Third Rock Ventures and was a 2017 “Fierce 15” company.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Other
Clinical Stage
Pre-Clinical Stage
Disease Space
Immuno-Oncology
Industry
Biotechnology
Listing
Private
Website:
Address:
100 Binney St
Suite 700
Cambridge, MA 02142
USA

Company Participants at Boston Private Company Showcase

  • Shakti Narayan, Ph.D., JD, Chief Business Officer